Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

INTRODUCTION: The aim of this study was to assess the efficacy of two dosing schedules of recombinant human erythropoietin (rHuEPO) in increasing haematocrit (Hct) and haemoglobin (Hb) and reducing exposure to allogeneic red blood cell (RBC) transfusion in critically ill patients. METHOD: This was a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Georgopoulos, Dimitris, Matamis, Dimitris, Routsi, Christina, Michalopoulos, Argiris, Maggina, Nina, Dimopoulos, George, Zakynthinos, Epaminondas, Nakos, George, Thomopoulos, George, Mandragos, Kostas, Maniatis, Alice
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2005
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297615/
https://ncbi.nlm.nih.gov/pubmed/16277712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3786
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky